Overview: Huntington Disease Mutation TestIntroduction: The Huntington Disease Mutation Test detects huntingtin gene mutations to diagnose Huntington's disease, causing movement disorders or cognitive decline. Following 2023 AAN guidelines, it uses PCR for high specificity, supporting genetic screening. This test is critical for guiding diagnosis, genetic counseling, and improving outcomes in molecular pathology for patients with suspected Huntington's disease.
Other Names: Huntingtin Gene Assay, Huntington's Disease Test.
FDA Status: Laboratory-developed test (LDT), meeting molecular pathology standards for diagnostic accuracy.
Historical Milestone: Huntington's disease genetic testing began in the 1990s after the huntingtin gene was identified. PCR-based methods improved diagnostic precision.
Purpose: Detects huntingtin gene mutations to diagnose Huntington's disease, guides genetic counseling, and evaluates patients with movement disorders or cognitive decline.
Test Parameters: 1. Huntingtin Gene Mutation
Pretest Condition: No fasting required. Collect whole blood, buccal swab, or saliva at any time. Report family history of Huntington's disease or neurological symptoms.
Specimen: 2-5 mL whole blood (EDTA), 1-2 buccal swabs (sterile swab), or 1-2 mL saliva (sterile container). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document movement disorders, cognitive decline, or family history of Huntington's disease. Include current medications and neurological symptoms.
Consent: Written consent required, detailing the tests purpose, genetic implications, and potential need for counseling or neurological management.
Procedural Considerations: Uses PCR to detect CAG repeat expansions in the huntingtin gene. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for genetic diagnosis.
Factors Affecting Result Accuracy: Improper sample handling or contamination can affect results. Low DNA quality may impact typing accuracy.
Clinical Significance: Expanded CAG repeats (36 or more) confirm Huntington's disease, guiding symptomatic treatment and counseling. Normal repeats rule out the disease but not other neurological conditions.
Specialist Consultation: Consult a neurologist or genetic counselor for result interpretation and management planning.
Additional Supporting Tests: Neurological exam, MRI, or genetic counseling to assess Huntington's disease or related conditions.
Test Limitations: Limited to huntingtin gene mutations; other neurological disorders may cause similar symptoms. Clinical correlation is needed.
References: AAN Huntington's Disease Guidelines, 2023; Neurology, Bates GP, 2022.
